Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vericel (VCEL) Cash & Equivalents: 2009-2024

Historic Cash & Equivalents for Vericel (VCEL) over the last 14 years, with Dec 2024 value amounting to $74.5 million.

  • Vericel's Cash & Equivalents rose 87.04% to $100.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $100.4 million, marking a year-over-year increase of 87.04%. This contributed to the annual value of $74.5 million for FY2024, which is 7.86% up from last year.
  • Latest data reveals that Vericel reported Cash & Equivalents of $74.5 million as of FY2024, which was up 7.86% from $69.1 million recorded in FY2023.
  • Vericel's Cash & Equivalents' 5-year high stood at $74.5 million during FY2024, with a 5-year trough of $33.6 million in FY2020.
  • In the last 3 years, Vericel's Cash & Equivalents had a median value of $69.1 million in 2023 and averaged $64.9 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 103.24% in 2021, then declined by 25.26% in 2022.
  • Yearly analysis of 5 years shows Vericel's Cash & Equivalents stood at $33.6 million in 2020, then soared by 103.24% to $68.3 million in 2021, then decreased by 25.26% to $51.1 million in 2022, then spiked by 35.29% to $69.1 million in 2023, then increased by 7.86% to $74.5 million in 2024.